A great advantage associated with the anti-cancer activity of rfhSP-D is induction of apoptosis by simultaneous targeting of multiple cellular signaling pathways including transcription factors, tumor cell survival factors, protein kinases resulting in the efficient and selective killing of prostate cancer cells. This evidence concerns the gene WEE1 and prostate carcinoma.